fda tirzepatide compounding moves to remove GLP-1 medications from 503B Bulks List The FDA is proposing a

Type 2 diabetes, for example, has been shown to slow the pace of weight loss on GLP-1 medications , such as tirzepatide

Contact your healthcare provider if you experience: Absent periods (amenorrhea): Missing three or more consecutive menstrual cycles if previously regular, or six or more months if previously irregular Heavy bleeding (menorrhagia): Soaking through a pad or tampon every hour for several consecutive hours, or periods lasting longer than seven days Severe pain: New or worsening menstrual cramping not relieved by over-the-counter medications Intermenstrual bleeding: Bleeding or spotting between periods that persists beyond initial treatment months Pregnancy possibility: Any missed period when pregnancy is possible, as tirzepatide is not recommended during pregnancy Urgent warning signs: Heavy bleeding with dizziness, fainting, rapid heartbeat, or severe weakness requires emergency evaluation Your healthcare provider may recommend specific investigations to evaluate persistent menstrual irregularities

Abdelsalam F

By addressing both issues simultaneously, you can optimize your weight loss journey and overall health

G., Kuhre, R